EX-32.1 5 tv515407_ex32-1.htm EXHIBIT 32.1


Exhibit 32.1




Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Neurotrope, Inc., a Nevada corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:


The Annual Report for the year ended December 31, 2018 (the “Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.


Dated: March 8, 2019 /s/ Charles S. Ryan, JD, PhD
  Name: Charles S. Ryan, JD, PhD
  Title: Chief Executive Officer
  Principal Executive Officer
Dated: March 8, 2019 /s/ Robert Weinstein
  Name: Robert Weinstein
  Title: Chief Financial Officer, Executive Vice President, Treasurer and Secretary
  Principal Financial Officer